Finance
Results: 4657-4668 of 44226

Alkermes Announces Initiation of Phase 3 Brilliance Studies Evaluating Alixorexton for the Treatment of Narcolepsy Type 1 and Type 2

Cambridge Isotope Laboratories Announces Eurisotop as Direct Supplier of Environmental Standards in Europe









